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Abstract The peptide hormone gastrin is an important fac-
tor for the maintenance and homeostasis of the gastric
mucosa. We show that gastrin stimulates proliferation in a
dose-dependent manner in the human gastric adenocarcino-
ma cell line AGS-GR. Furthermore, we demonstrate that the
MAPK scaffold protein MEK partner 1 (MP1) is important
for gastrin-induced phosphorylation of ERK1 and ERK2
and that MP1 promotes gastrin-induced proliferation of
AGS-GR cells. Our results suggest a role of MP1 in
gastrin-induced cellular responses involved in proliferation
and homeostasis of the gastric mucosa.
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Introduction
The peptide hormone gastrin plays a central role in gastric
acid secretion (Edkins 1906), differentiation of the gastric
mucosa (Koh et al. 1997), maintenance, homeostasis, and
epithelial organization of the cells in the gastric mucosa
(Dockray et al. 2001). In addition to its role in regulation
of normal physiological processes, gastrin may also be an
important player in gastric carcinogenesis (Watson et al.
2006). Gastrin is shown to exert growth-promoting effects
in both normal and malignant gastrointestinal tissues like the
oxyntic mucosa (Wang et al. 1996) and gastric epithelial
cells (Wang et al. 2000). Several studies have demonstrated
that gastrin stimulates growth of human gastric cell lines
(Ishizuka et al. 1992), pancreatic cell lines (Seva et al. 1990;
Smith et al. 1994), and human and mouse colonic tumors
(Smith et al. 1993). Interestingly, Varro et al. (2002) have
used a co-culture system to show that gastrin causes sup-
pression of proliferation in cells expressing the gastrin re-
ceptor, CCK2R, and a subsequent activation of proliferation
in cells that do not express these receptors. They demon-
strate that these signals are transferred via paracrine activa-
tion of the epidermal growth factor receptor (Varro et al.
2002). However, the growth-regulatory mechanisms are
complex since gastrin also has been found to have both
growth-promoting and inhibitory effects in different cells
and cell lines expressing CCK2R (Smith et al. 1994;
Seufferlein et al. 1995; Detjen et al. 1997a, b; Muerkoster
et al. 2005). In addition to its growth-promoting effects,
gastrin may also induce oncogenic transformation via in-
creased cell migration (Noble et al. 2003), invasion
(Wroblewski et al. 2002), and circumvention of apoptosis
(Todisco et al. 2001; Fjeldbo et al. 2012). The ambiguous
responses to gastrin indicate that gastrin plays pivotal roles
in the regulation of many cellular processes, and the overall
response to gastrin is governed by multiple intricate
mechanisms.
To investigate the molecular mechanisms underlying
gastrin-mediated cellular responses in a genome-wide ap-
proach, we carried out several time-series gene expression
microarray studies covering the first 14–24 h of gastrin
response in rat pancreatic AR42J cells. The studies identify
a number of gastrin-responsive genes, many of which have
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not previously been described to be regulated by gastrin (E-
MTAB-123 and GSE32869). In the present study, we focus
on one of the new gastrin target genes based on its possible
roles in cellular proliferation: Mitogen activated protein
kinase kinase 1 interacting protein 1 (Map2k1ip1, MEK
partner 1, Lamtor3, or MP1).
MP1 was first identified as a scaffold protein enhancing
the efficiency of the MAPK pathway by facilitating the
interaction between MEK1 and ERK1 upon serum stimula-
tion (Schaeffer et al. 1998). Later, it has been demonstrated
that MP1 enhances activation of both ERK1 and ERK2 as a
response to EGF (Teis et al. 2002) and fibronectin (Pullikuth
et al. 2005). MP1 is recruited to late endosomes by the
adaptor protein p14 (Teis et al. 2002), and the protein
complex p14–MP1–MEK1 is involved in regulating endo-
somal trafficking and cellular proliferation during tissue
homeostasis (Teis et al. 2006). MP1 has also been found
to regulate cell spreading by integrating PAK1 and Rho
signals (Pullikuth et al. 2005). A recent report has unmasked
a novel lipid raft adaptor on late endosomes, p18, which
controls endosome dynamics by anchoring p14–MP1 in
complex with MEK1 and ERK1 to the membranes of late
endosomes (Nada et al. 2009). The present study demon-
strates that gastrin induces proliferation in a dose-dependent
manner and suggests a role of MP1 in regulation of prolif-
eration via CCK2R and ERK1/2 signaling in gastric epithe-
lial AGS-GR cells.
Materials and Methods
Cells and reagents. AGS (human gastric adenocarcinoma,
ATCC, Rockville, MD) and AGS-GR cells (AGS stably
transfected with the CCK2 receptor (Watson et al. 2001;
Varro et al. 2002); gift from Prof. A. Varro, University of
Liverpool, England) were grown in Ham's F12 (Invitrogen,
Carlsbad, CA) supplemented with 10% fetal calf serum
(FCS; Euroclone, Devon, UK), 10 U/ml penicillin–strepto-
mycin (Invitrogen), and 2 μg/ml puromycin (Sigma
Chemical, St. Louis, MO) (AGS-GR cells). AR42J (rat pan-
creatic acinar cell-derived; ATCC) were grown in DMEM
with 4.5 g/l glucose (Invitrogen), 15% FCS, 1 mM sodium
pyruvate (Invitrogen), 0.1 mg/ml L-glutamine (Invitrogen),
10 U/ml penicillin/streptomycin (Invitrogen), and 1 μg/ml
fungizone (Invitrogen). Gastrin-17 was purchased from
Sigma.
xCELLigence proliferation assay. Adherent cell prolifera-
tion was measured in a label-free, real-time manner using
xCELLigence Technology. This system utilizes specialized
culture plates that contain gold electrode arrays at the
bottom of individual wells (Roche Applied Science).
Cellular contact with the electrode surfaces increases the
impedance across these gold arrays. This impedance value
is measured by the RTCA SP system and is reported in the
dimensionless unit of cell index. The day before seeding,
sub-confluent cells were split 1:2 in order for cells to be in
exponential growth phase at the time of seeding for
xCELLigence analysis. Prior to seeding of cells in the 96-
well E-plate, 50 μl plain medium was added to wells, and
background read was recorded. Wild-type AGS and AGS-
GR cells were split, and 5×10
4 cells in 100 μl medium were
added to each well. Finally, 50 μl medium containing gastrin to
0.1–100 nM or 100 ng/ml human recombinant EGF (Sigma)
final concentration in either absence or presence of 10% serum
was added to the cells. Real-timemonitoring of cell proliferation
measured as cell index was recorded every 5 min for up to 70 h.
Real-time RT-PCR. Total RNA from 6-well plates was iso-
lated using RNeasy Mini kit (Qiagen, Germantown, MD)
according to the manufacturer's protocol. cDNA synthesis
was performed with 1 μg of total RNA in a 20-μl reaction of
Reverse-iT First Strand Synthesis kit according to the man-
ufacturer's instruction (Abgene, Rockford, IL). After syn-
thesis, the cDNA was diluted 1:4 with RNase-free water.
SYBR Green real-time PCR was run in 1x ABsolute™
QPCR SYBR® Green Mix (Abgene) with 70 nM of each
primer and cDNA equivalent to 31.3 ng total RNA.
Real-time PCR was performed in Stratagene's Mx3000P
real-time PCR system: 15 min at 95°C, 40 thermal cycles
of 15 s at 95°C, 1 min at 56–60°C, and 30 s at 72°C. PCR
products were verified by a dissociation curve analysis to
confirm primer specificity. PCR products were analyzed on
agarose gels. Fold induction levels were calculated using the
ΔΔCt-method (Livak and Schmittgen 2001).
Primer sequences. Human-MP1 S: 5′-ACCAGGTG
GTTCAATTTAATCG-3 ′ , h uman -MP1 AS : 5 ′ -
CTTCAAACAATGGAGCAAGTTC-3′, human-GAPDH
S: 5 ′-TCTGACTTCAACAGCGACACC-3 ′, human-
GAPDH AS: 5′-TGTTGCTGTAGCCAAATTCGT-3′, rat-
MP1 S: 5′-AAGTTGCCAAGCGTTGAAGG-3′, rat-MP1
AS: 5′-GGCGAAAGTGGACAAGAAG-3′, rat β-actin S:
5′-CTGGCTCCTAGCACCATGA-3′, and rat β-actin AS:
5′-AGCCACCAATCCACACAGA-3′.
RNA interference experiments. For transfection with
siRNAs, AGS-GR cells (2×10
5) were seeded in 6-well
plates. The cells were transfected 24 h after seeding using
2.5 μg (81 nM) siRNA and 12.5 μl Metafectene™ PRO
(Biontex, Martinsried/Planegg, Germany) diluted in Ham's
F12 in accordance with manufacturer's protocol. Cells were
transfected for 24–48 h before further processing.
siRNA oligonucleotides. Human siRNA oligonucleotides
were purchased from Ambion (Carlsbad, CA): siMP1
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(ID#138573), siCycD1 (ID#42828), and Silencer Negative
Control siRNA#1 (siCtr).
Western blot analysis. Cells growing in 6-well plates were
harvested and subjected to western blot analysis as de-
scribed previously (Steigedal et al. 2007). Binding of sec-
ondary antibodies was visualized by the SuperSignal West
Femto detection system (Pierce, Rockford, IL) and Kodak
Image Station 2000R (Kodak, Pittsburgh, PA). The follow-
ing antibodies were used: rabbit anti-mouse MP1 (gift from
Prof. A. Catling), mouse anti human p-ERK1/2 (Santa Cruz
Biotechnology, Santa Cruz, CA), mouse anti-human β-actin
(Abcam, Cambridge, UK), rabbit anti-human GAPDH
(Santa Cruz), HRP-conjugated goat anti-rabbit IgG (Cell
Signaling, Danvers, MA), and HRP-conjugated goat anti-
mouse (Dako, Glostrup, Denmark).
Flow cytometry. Cells (2×105) were seeded in 6-well plates
and transfected the following day. Twenty-four hours after
transfection, the cells were treated with 10 nM gastrin with-
out medium replacement. The cells were stimulated for 24 h
before they were harvested and subjected to cell cycle
analysis according to a modified version of the Vindelov
protocol (Vindelov et al. 1983) using 416 ng/μl propidium
iodide (Sigma). The nuclei were filtered through a 40-μm
nylon mesh and subjected to a BD FACS LSRII flow
cytometer (BD Biosciences). Cell cycle data was analyzed
in FlowJo 7.5 (Tree Star Inc., Ashland, OR).
Statistical analysis. xCELLigence proliferation assays were
performed three times with four technical replicates in each
experiment. The data is represented as mean±SD.
Quantitative RT-PCRs were run three times, with three
technical replicates in each run and data presented as
mean±SD. Flow cytometry experiments were performed
three times and data presented as mean±SD.
Results
Gastrin stimulates proliferation in a dose-dependent manner
in human AGS-GR cells. Gastrin may mediate proliferation,
differentiation, or apoptosis depending on cell type, tissue,
and organ (Seva et al. 1990; Ishizuka et al. 1992; Smith et al.
1993, 1994; Wang et al. 1996; Detjen et al. 1997a, b; Wang
et al. 2000; Varro et al. 2002; Muerkoster et al. 2005). We
wanted to employ the gastric cell line AGS-GR, overex-
pressing CCK2R, to study mechanisms involved in
gastrin-mediated proliferation. Reports in the literature are
conflicting with regard to the ability of gastrin to induce
proliferation in cell lines. Varro et al. (2002) observed an
inhibitory effect of gastrin-mediated proliferation on AGS-
a
b
Figure 1. xCELLigence proliferation assay of wild-type AGS and
AGS-GR cells in response to gastrin. AGS and AGS-GR cells were
seeded in 96-well E-plates for xCELLigence assay monitoring imped-
ance (cell index). The cells were treated with either 10% FCS or
100 ng/ml EGF as controls or gastrin at different concentrations (0.1,
1, 10, or 100 nM) in either absence or presence of serum. (a) Complete
growth curves of AGS and AGS-GR cells from 0 to 70 h after seeding.
The cells were treated with gastrin and EGF in absence of serum. Panel
to the right shows bar graph of cell index at 24 h growth. (b) Complete
growth curves of AGS and AGS-GR cells from 0 to 70 h after seeding.
The cells were treated with gastrin and EGF in presence of serum.
Panel to the right shows bar graph of cell index at 24 h growth. Data is
represented as mean±SD of three independent experiments.
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GR cells. There are also reports demonstrating both stimu-
lation and inhibition of proliferation via CCK2R in AR42J
cells (Bestervelt et al. 2000; Hofsli et al. 2002). Using the
relatively new xCELLigence technology, we were able to
study the complete proliferative response to gastrin in a real-
time manner. We investigated the effect of gastrin in cells
subjected to a variety of stimulation conditions. AGS-GR
cells were treated with several different gastrin concentra-
tions in either absence (Fig. 1a) or presence (Fig. 1b) of
serum, and proliferation was measured with real-time cell
index as output. We observed a dose-dependent proliferative
effect when cells were treated with gastrin both in absence
and presence of serum. This finding demonstrates that gas-
trin enhances proliferation in actively growing AGS-GR
cells. Wild-type AGS cells (without CCK2R) did not show
any response to gastrin, suggesting that the observed effect
was mediated via the CCK2R. We (Hofsli et al. 2002) and
others (Bestervelt et al. 2000) have previously shown that
gastrin promotes proliferation of AR42J cells, and Varro et
al. (2002) have shown a growth inhibitory effect of gastrin
in AGS-GR cells. Our findings are in keeping with the
assumption that gastrin exhibits both proliferative and anti-
proliferative properties depending on the cell type as well as
the cell state at the onset of gastrin treatment, but the assay
for monitoring proliferation may also be important as real-
time monitoring gives a better picture than classical end-
point proliferation assays.
Gastrin induces expression of MP1 in both AR42J and AGS-
GR cells. Our whole genome microarray gene expression
screening indicated that the gastrin-responsive gene MP1 is
an early response primary gastrin target gene that is upregu-
lated within 4 h after onset of gastrin treatment in pancreatic
AR42J cells (E-MTAB-123 and GSE32869). In order to
validate the time profile observed by microarray analysis,
expression of MP1 was measured by quantitative RT-PCR.
The results showed increasing MP1 levels up to 2 h of
gastrin treatment, followed by sustained mRNA levels up
to 6 h in AR42J cells (Fig. 2a). In AGS-GR cells, the peak
expression for MP1 was at 4 h followed by a rapid decrease
(Fig. 2b). MP1 protein expression assessed by Western blot
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activation of MP1 in AR42J and
AGS-GR cells. (a) Verification of
gene expression microarray
results with quantitative RT-PCR
in AR42J. Cells were seeded in
6-well plates and serum starved
for 24 h the following day prior to
treatment with gastrin (10 nM) as
indicated in figure. (b) Quantita-
tive RT-PCR analysis of MP1
expression in AGS-GR. Cells
were seeded in 6-well plates and
cultivated 24 h prior to gastrin
treatment (10 nM) as indicated in
figure. Fold induction levels were
calculated using the ΔΔCt-meth-
od (Livak and Schmittgen 2001),
where the expression levels were
normalized to the level of β-actin
(AR42J) or GAPDH (AGS-GR)
expression, and gastrin-treated
cells were compared to untreated
cells. One representative experi-
ment is shown and data presented
as mean±SD of three technical
replicates. (c) Western blot of
AGS-GR lysates from cells treated
with 10 nM of gastrin
2–10 h before harvesting. The
blot was treated with non-com-
mercial antibodies against MP1,
and β-actin was used as loading
control. Lower panels show rela-
tive quantification of band inten-
sities from western blot analysis.
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of gastrin treatment (Fig. 2c). Together, these results dem-
onstrate that MP1, previously not described in the gastrin
response, is induced by gastrin in a relatively comparable
manner in both AR42J and AGS-GR cells.
MP1 is essential for gastrin-induced phosphorylation of
ERK1 and ERK2. MP1 has been shown to be involved in
activation of both ERK1 and ERK2 (Schaeffer et al. 1998;
Teis et al. 2002; Pullikuth et al. 2005). Since gastrin is
known to induce phosphorylation of ERKs (Seufferlein et
al. 1995; Todisco et al. 1995), it was of interest to investi-
gate the functional role of MP1 in the gastrin response. We
therefore assessed gastrin-induced phosphorylation of
ERK1 and ERK2 in AGS-GR cells in the presence or ab-
sence of siRNA targeting MP1. The results showed that in
cells treated with siMP1, gastrin induced markedly lower
levels of both ERK1 and ERK2 phosphorylation compared
to cells treated with control siRNA at all time-points ana-
lyzed (Fig. 3a). Densiometric measurements using GAPDH
as control verified this finding (Fig. 3b, c). The results
demonstrate for the first time that MP1 is involved in
gastrin-induced activation of the MAPK pathway. This find-
ing supports our hypothesis that MP1 is an important factor
in gastrin-induced activation of processes downstream of the
MAPK pathway.
MP1 promotes gastrin-induced proliferation. The MAPK
pathway is central for cell proliferation (Hill and Treisman
1995). Since MP1 enhanced gastrin-induced activation of
ERK1 and ERK2, and gastrin-mediated signaling is shown
to be transduced via the MAPK pathway (Stepan et al.
1999), we investigated whether MP1 may be involved in
gastrin-induced cell cycle regulation. We performed cell
cycle analysis using flow cytometry on AGS-GR cells in
the presence or absence of siMP1. siCycD1 was included as
a positive control since Cyclin D1 is known to be required
for G1/S transition (Baldin et al. 1993). The cell cycle
profile in siCycD1-treated cells showed, as expected, a
lower proportion of S-phase cells compared to controls in
both untreated and gastrin-treated cells (20.2% and 24.3%,
respectively; Fig. 4). Similarly, MP1 depletion induced G1
cell cycle arrest in both untreated and gastrin-treated cells.
The proportion of S-phase cells in gastrin-treated siMP1-
transfected samples versus siCtr-transfected was 22.5% and
31.7%, respectively. In untreated cells, the proportion was
20.0% (siMP1) and 26.6% (siCtr). For all siRNA treat-
ments, we observed that gastrin was a strong enhancer of
proliferation, and neither siCycD1 nor siMP1 treatment was
able to circumvent this effect, as reflected in the fact that the
overall fold change of cells in S-phase before and after
gastrin treatment was not altered in cells treated with
siMP1 or siCycD1 compared to controls. Our results show-
ing that MP1 depletion induces G1 cell cycle arrest to a
similar extent as Cyclin D1 depletion indicate that MP1
plays a role in regulation of proliferation, but this effect is
not restricted to proliferation induced by gastrin. The fact
that single-gene knockdown of essential cell cycle genes
does not halt proliferation is in keeping with other studies
(Kozar and Sicinski 2005).
Discussion
The purpose of the present study was to enhance our knowl-
edge of molecular mechanisms by which gastrin regulate
proliferation. Gastrin has been shown to display proliferative,
anti-apoptotic, and anti-proliferative properties, dependent on
siMP1
siCtr
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Figure 3. MP1 depletion reduces gastrin-induced phosphorylation of
ERK1 and ERK2 (p-ERK1/2). (a) AGS-GR cells were transfected with
siMP1 and siCtr for 24 h. Then, the cells were serum starved for 24 h
and treated with 10 nM gastrin for 5 to 30 min before harvesting.
Protein extracts were subjected to SDS-PAGE and analyzed for p-
ERK1 and p-ERK2 in addition to GAPDH (loading control). (b, c)
Densiometric analysis of relative amounts of p-ERK1 and p-ERK2,
respectively. One representative experiment is shown. Similar results
were obtained three times.
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cell type, tissue, or context (Yassin 1999; Dockray et al. 2005;
Watson et al. 2006; Dimaline and Varro 2007; Grabowska and
Watson 2007). We show that gastrin induces proliferation in
AGS-GR cells in a dose-dependent manner. We recently iden-
tified MP1 to be among a large number of new gastrin target
genes (E-MTAB-123 and GSE32869), many of which may be
involved in gastrin-mediated proliferation. Here, we show that
MP1 is necessary for gastrin-induced phosphorylation of
ERK1 and ERK2 and that it may be involved in mediating
gastrin-induced proliferation of AGS-GR cells. The present
study reports for the first time evidence indicating that MP1 is
involved in gastrin-mediated responses coupled to prolifera-
tion and possibly carcinogenesis.
MP1 was first identified to be a scaffold protein enhanc-
ing the efficiency of the MAPK pathway in response to
serum stimulation in COS-1 cells (Schaeffer et al. 1998),
and later, MP1 was shown to be involved in endosomal
trafficking of EGF receptor and cell proliferation in mice
(Teis et al. 2006). Further investigations on MP1 have also
revealed its role in positive regulation of fibroblast cell
Untransf. siCtr siMP1 siCycD1

































Figure 4. MP1 enhances cell cycle progression. AGS-GR cells were
grown and treated with siCtr, siMP1, or siCycD1. Cells were treated
with 10 nM gastrin without medium replacement 24 h after transfection
and then grown for another 24 h. Finally, the cells were harvested in
citrate buffer and treated with buffers A, B, and C according to a
slightly modified version of the Vindelov protocol (Vindelov et al.
1983). The proportion of cells in S-phase of the cell cycle in untreated
(black) and gastrin-treated (red) bars. DNA histograms were created
from 20,000 propidium iodide stained nuclei. Representative histo-
grams are shown, and data is presented as percent cells in S-phase
mean±SD (n=3). Using qRT-PCR, MP1 depletion was found to be
approximately 90% (data not shown).
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spreading on fibronectin in vitro (Pullikuth et al. 2005). Our
findings, demonstrating that MP1 is involved in gastrin-
induced phosphorylation of ERK1 and ERK2, are in keep-
ing with previous findings on its molecular function in
growth stimulatory responses (Pullikuth et al. 2005; Teis et
al. 2006). Indeed, the observation that siRNA knockdown of
MP1 induced G1 cell cycle arrest to a similar extent as the
positive control, Cyclin D1, strongly suggests that MP1 is a
positive regulator of gastrin-induced cell cycle entry. Taken
together, our results indicate that gastrin-mediated activation
of the MAPK pathway, which is known to be required for its
induction of proliferation (Stepan et al. 1999), involves
facilitation of the phosphorylation of ERK1 and/or ERK2
by MP1 scaffold activity.
Our finding that MP1 depletion induces cell cycle arrest
completes the picture of MP1 as a significant factor in
regulation of proliferation. Addition of gastrin increased
the proportion of S-phase cells in siMP1-transfected cells,
but not completely to the same level as in untreated siCtr-
transfected samples. This finding underpinned the strong
proliferation-inhibiting effect of MP1 depletion.
Recently, PAK1 was identified to be involved in gastrin
signal transduction, as it was found to be required for gastrin-
induced activation of the β-catenin pathway (He et al. 2008).
In addition, activation of the β-catenin pathway is shown to
increase expression of genes like c-myc and Cyclin D1 (He et
al. 1998; Shtutman et al. 1999). Taken together, the findings
that PAK1 is involved in gastrin-mediated signaling and that
MP1 regulates cell spreading via PAK1 signals (Pullikuth et
al. 2005) suggest that PAK1 and MP1 may participate in the
same pathway, integrating signals leading to gastrin-induced
cellular responses. Further studies could therefore focus on the
role of MP1 in gastrin-mediated signaling via PAK1 and other
carcinogenesis-related processes.
MP1 was chosen for further studies due to its possible
involvement in gastrin-induced responses linked to prolifer-
ation mainly by facilitating signaling via the MAPK path-
way acting as a molecular scaffold. The roles of such
specific interactions in the spatiotemporal organization of
protein complexes seem to facilitate a fine-tuning of
context-specific signaling. Further studies on MP1 could
focus on further characterization of the detailed mechanisms
in the scaffolding functions and its role in carcinogenic
processes.
Conclusion
Our data shows that gastrin promotes cell proliferation in the
human gastric adenocarcinoma cell line AGS-GR in a dose-
dependent manner. We show that gastrin induces transcrip-
tion of a scaffold protein, MP1, both in the neuroendocrine
pancreatic cell line AR42J and AGS-GR cells. Our results
highlight that MP1 is important for gastrin-induced phos-
phorylation of ERK1 and ERK2, and that MP1 promotes
gastrin-induced proliferation. Taken together, our data sug-
gest a new role for MP1 in regulation of cellular prolifera-
tion, and our findings are in keeping with MP1 as a scaffold
protein promoting MAPK signaling pathway flux and sug-
gest new insights into some of the complex mechanisms of
tumorigenesis.
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